Skip to main content
H.R. 3789 119th Congress House

DTC Act of 2025

Official title: To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.

Introduced: June 5, 2025 Introduced by: David J. Taylor Republican · Ohio See on congress.gov
Health
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 5, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 5, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now June 5, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

 Related & companion bills 1
  • S 229 Identical bill DTC Act of 2025
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 28

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

See all 28 filings →
 Cosponsors 8
All 8 Democratic 4 Republican 4
R
Hinson, Ashley
Iowa · Jan 13, 2026
 D
Vindman, Eugene Simon
Virginia · Oct 21, 2025
 R
Nunn, Zachary
Iowa · Oct 3, 2025
 R
Bresnahan, Robert P.
Pennsylvania · Sep 30, 2025
 D
Norton, Eleanor Holmes
District of Columbia · Sep 30, 2025
 R
Begich, Nicholas J.
Alaska · Jul 2, 2025
 D
Quigley, Mike
Illinois · Jul 2, 2025
 D
Schakowsky, Janice D.
Illinois · Jun 5, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3789: DTC Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-3789/
MLA
"H.R. 3789: DTC Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-3789/.
Bluebook (legal)
H.R. 3789, 119th Cong. (2026), https://openamerica.io/bill/119-HR-3789/.
Markdown link
[H.R. 3789: DTC Act of 2025](https://openamerica.io/bill/119-HR-3789/)
Report a problem